Navigation Links
Researchers gain new insights into how tumor cells are fed
Date:8/7/2011

Philadelphia, PA, August 8, 2011 Researchers have gained a new understanding of the way in which growing tumors are fed and how this growth can be slowed via angiogenesis inhibitors that eliminate the blood supply to tumors. This represents a step forward towards developing new anti-cancer drug therapies. The results of this study have been published today in the September issue of The American Journal of Pathology.

"The central role of capillary sprouting in tumor vascularization makes it an attractive target for anticancer therapy. Our observations suggest, however, that targeting just this mode of blood vessel formation may not be sufficient to result in a significant antitumor effect," commented lead investigators Sndor Paku, PhD, Semmelweis University, Budapest, and Balazs Dome, MD, PhD, Medical University of Vienna.

Investigators from the Semmelweis University, the National Institute of Oncology, and the National Koranyi Institute of Pulmonology, Budapest, Hungary, and the Medical University of Vienna, Vienna, Austria, used electron and confocal microscopy to examine tumor tissue in mice in which malignant tumor cells had been introduced. They proposed a novel mechanism for the development of tissue pillars (the most characteristic feature of intussusceptive angiogenesis, in which a vessel folds into itself to form two vessels). Moreover, they demonstrated a significant increase in pillar formation after treatment with the angiogenesis inhibitor vatalanib. Their observations support the notion that inhibition of just a single tumor vascularization mechanism can trigger alternative ones.

Prior to this study, the mechanism of pillar formation had not been fully understood. Investigation revealed a progression of events that generates a connection between the processes of endothelial bridging and intussusceptive angiogenesis resulting in rapid pillar formation from pre-existing building blocks. To describe this mechanism of pillar formation the group coined the term "inverse sprouting."

"It is well established now that tumors can obtain sufficient blood supply from alternative vascularization mechanisms (such as intussusceptive angiogenesis) to grow without capillary sprouting (known as the key mode of new vessel formation in cancer). Therefore, antiangiogenic therapies should be tailored depending on the angiogenic phenotype in each single tumor, and the targeting of non-sprouting angiogenic mechanisms in cancer seems to be a rational strategy. Our study provides new understanding of cancer-induced intussusceptive angiogenesis and may serve as a basis for the development of novel drugs targeting this type of blood vessel formation."


'/>"/>

Contact: David Sampson
ajpmedia@elsevier.com
215-239-3171
Elsevier Health Sciences
Source:Eurekalert

Related biology news :

1. University of Virginia researchers uncover new catalysis site
2. U of Minnesota researchers discover a natural food preservative that kills food-borne bacteria
3. Researchers develop fully cooked food-aid product
4. U of M researchers use improved imaging technique; discover a better approach to diagnosing epilepsy
5. RUB researchers decipher the molecular basis of blue-green algae
6. Researchers discover the mechanism that determines cell position in the intestinal epithelium
7. Caltech researchers increase the potency of HIV-battling proteins
8. Researchers tap yeasts as source of green surfactants
9. Lawson researchers take control of cancer
10. U researchers look to dogs to better understand intricacies of bone cancer
11. Penn researchers help graft olfactory receptors onto nanotubes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/11/2017)... N.Y. , April 11, 2017 ... fingerprints, but researchers at the New York University ... College of Engineering have found that partial similarities ... security systems used in mobile phones and other ... thought. The vulnerability lies in the ...
(Date:4/5/2017)... , April 5, 2017  The Allen Institute for ... Cell Explorer: a one-of-a-kind portal and dynamic digital window ... imaging data, the first application of deep learning to ... stem cell lines and a growing suite of powerful ... for these and future publicly available resources created and ...
(Date:4/4/2017)... 2017   EyeLock LLC , a leader of ... States Patent and Trademark Office (USPTO) has issued U.S. ... of an iris image with a face image acquired ... company,s 45 th issued patent. ... given the multi-modal biometric capabilities that have recently come ...
Breaking Biology News(10 mins):
(Date:7/18/2017)... ... July 18, 2017 , ... Genedata, a leading provider of ... technology company, has implemented Genedata Biologics ™ to scale-up their bispecific antibody ... and Neurodegenerative Diseases. , The need to systematically evaluate large panels of ...
(Date:7/18/2017)... ... July 18, 2017 , ... Allotrope Foundation won ... first phase of the Allotrope Framework for commercial use. , The Bio-IT World ... “not only elevate the critical role of information technology in modern biomedical research, ...
(Date:7/17/2017)... (PRWEB) , ... July 17, 2017 , ... The Academy ... local celebration of National Model Aviation Day will take place from 9 a.m. to ... and will include activities for all ages. , Aviation Adventure Day will be packed ...
(Date:7/17/2017)... ... 17, 2017 , ... Neurodevelopmental disorders (NDDs) are clinically and ... features. The advancement of targeted next-generation sequencing (NGS) has been instrumental in accelerating ... , However, designing a custom panel for disease research requires hours of up-front ...
Breaking Biology Technology: